InvestorsObserver
×
News Home

Apellis Pharmaceuticals Inc (APLS) is down -1.18% in a Week, Should You Accumulate?

Tuesday, January 03, 2023 03:14 PM | InvestorsObserver Analysts

Mentioned in this article

Apellis Pharmaceuticals Inc (APLS) is down -1.18% in a Week, Should You Accumulate?

Apellis Pharmaceuticals Inc (APLS) is around the top of the Biotechnology industry according to InvestorsObserver. APLS received an overall rating of 61, which means that it scores higher than 61 percent of all stocks. Apellis Pharmaceuticals Inc also achieved a score of 73 in the Biotechnology industry, putting it above 73 percent of Biotechnology stocks. Biotechnology is ranked 41 out of the 148 industries.

Overall Score - 61
APLS has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on APLS!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 61 means the stock is more attractive than 61 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Apellis Pharmaceuticals Inc Stock Today?

Apellis Pharmaceuticals Inc (APLS) stock is trading at $50.26 as of 3:13 PM on Tuesday, Jan 3, a loss of -$1.45, or -2.8% from the previous closing price of $51.71. The stock has traded between $49.52 and $52.32 so far today. Volume today is less active than usual. So far 501,477 shares have traded compared to average volume of 1,163,362 shares. Click Here to get the full Stock Report for Apellis Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App